Table of Content


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Cancer biological therapy market industry 360 degree synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Route of administration trends
2.1.4 Regional trends
Chapter 3 Cancer Biological Therapy Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing incidence of cancer worldwide
3.3.1.2 Growing geriatric population
3.3.1.3 Technological advancement in cancer biologics in developed countries
3.3.1.4 Increasing R&D funding coupled with favourable government policies
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost of treatment
3.3.2.2 Adverse effects of anti-cancer drug therapy
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By route of administration
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2020
3.7.1 Company matrix analysis
3.8 PESTEL analysis
Chapter 4 Cancer Biological Therapy Market, By Product
4.1 Key segment trends
4.2 Monoclonal antibodies (MAB)
4.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.2 Naked MAB
4.2.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.3 Conjugated MAB
4.2.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.4 Bispecific MAB
4.2.4.1 Market size, by region, 2016 – 2027 (USD Million)
4.3 Vaccines
4.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.3.2 Preventive vaccines
4.3.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.3.3 Therapeutic vaccines
4.3.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.4 Cancer growth blockers
4.4.1.1 Market size, by region, 2016 – 2027 (USD Million)
4.4.2 Tyrosine kinase Inhibitors (TKI)
4.4.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.4.3 Proteasome Inhibitors (PI)
4.4.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.4.4 mTOR Inhibitors
4.4.4.1 Market size, by region, 2016 – 2027 (USD Million)
4.5 Blood cell growth factors (BCGF)
4.5.1 Market size, by region, 2016 – 2027 (USD Million)
4.5.2 Lenograstim
4.5.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.5.3 Filgrastim
4.5.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.6 Cytokines
4.6.1 Market size, by region, 2016 – 2027 (USD Million)
4.6.2 Interferons
4.6.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.6.3 Interleukins
4.6.3.1 Market size, by region, 2016 – 2027 (USD Million)
Chapter 5 Cancer Biological Therapy Market, By Route of administration
5.1 Key segment trends
5.2 Oral
5.2.1 Market size, 2016 - 2027 (USD Million)
5.3 Injectable
5.3.1 Market size, 2016 - 2027 (USD Million)
Chapter 6 Cancer Biological Therapy Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country, 2016 - 2027 (USD Million)
6.2.2 Market size, by product, 2016 - 2027 (USD Million)
6.2.2.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.2.2.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.2.2.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.2.2.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.2.2.5 Market size, by cytokines, 2016 - 2027 (USD Million)
6.2.3 Market size, by route of administration, 2016 - 2027 (USD Million)
6.2.4 U.S.
6.2.4.1 Market size, by product, 2016 - 2027 (USD Million)
6.2.4.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.2.4.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.2.4.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.2.4.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.2.4.1.5 Market size, by cytokines, 2016 - 2027 (USD Million)
6.2.4.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.2.5 Canada
6.2.5.1 Market size, by product, 2016 - 2027 (USD Million)
6.2.5.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.2.5.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.2.5.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.2.5.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.2.5.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.2.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.3 Europe
6.3.1 Market size, by country, 2016 - 2027 (USD Million)
6.3.2 Market size, by product, 2016 - 2027 (USD Million)
6.3.2.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.3.2.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.3.2.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.3.2.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.3.2.5 Market size, by cytokines, 2016 - 2027 (USD Million)
6.3.3 Market size, by route of administration, 2016 - 2027 (USD Million)
6.3.4 Germany
6.3.4.1 Market size, by product, 2016 - 2027 (USD Million)
6.3.4.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.3.4.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.3.4.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.3.4.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.3.4.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.3.4.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.3.5 UK
6.3.5.1 Market size, by product, 2016 - 2027 (USD Million)
6.3.5.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.3.5.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.3.5.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.3.5.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.3.5.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.3.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.3.6 France
6.3.6.1 Market size, by product, 2016 - 2027 (USD Million)
6.3.6.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.3.6.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.3.6.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.3.6.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.3.6.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.3.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.3.7 Spain
6.3.7.1 Market size, by product, 2016 - 2027 (USD Million)
6.3.7.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.3.7.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.3.7.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.3.7.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.3.7.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.3.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.3.8 Italy
6.3.8.1 Market size, by product, 2016 - 2027 (USD Million)
6.3.8.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.3.8.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.3.8.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.3.8.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.3.8.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.3.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.4 Asia Pacific
6.4.1 Market size, by country, 2016 - 2027 (USD Million)
6.4.2 Market size, by product, 2016 - 2027 (USD Million)
6.4.2.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.4.2.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.4.2.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.4.2.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.4.2.5 Market size, by cytokines, 2016 - 2027 (USD Million)
6.4.3 Market size, by route of administration, 2016 - 2027 (USD Million)
6.4.4 Japan
6.4.4.1 Market size, by product, 2016 - 2027 (USD Million)
6.4.4.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.4.4.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.4.4.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.4.4.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.4.4.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.4.4.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.4.5 China
6.4.5.1 Market size, by product, 2016 - 2027 (USD Million)
6.4.5.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.4.5.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.4.5.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.4.5.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.4.5.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.4.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.4.6 India
6.4.6.1 Market size, by product, 2016 - 2027 (USD Million)
6.4.6.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.4.6.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.4.6.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.4.6.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.4.6.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.4.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.4.7 Australia
6.4.7.1 Market size, by product, 2016 - 2027 (USD Million)
6.4.7.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.4.7.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.4.7.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.4.7.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.4.7.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.4.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.5 Latin America
6.5.1 Market size, by country, 2016 - 2027 (USD Million)
6.5.2 Market size, by product, 2016 - 2027 (USD Million)
6.5.2.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.5.2.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.5.2.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.5.2.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.5.2.5 Market size, by cytokines, 2016 - 2027 (USD Million)
6.5.3 Market size, by route of administration, 2016 - 2027 (USD Million)
6.5.4 Brazil
6.5.4.1 Market size, by product, 2016 - 2027 (USD Million)
6.5.4.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.5.4.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.5.4.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.5.4.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.5.4.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.5.4.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.5.5 Argentina
6.5.5.1 Market size, by product, 2016 - 2027 (USD Million)
6.5.5.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.5.5.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.5.5.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.5.5.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.5.5.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.5.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.5.6 Mexico
6.5.6.1 Market size, by product, 2016 - 2027 (USD Million)
6.5.6.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.5.6.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.5.6.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.5.6.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.5.6.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.5.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.6 Middle East & Africa
6.6.1 Market size, by country, 2016 - 2027 (USD Million)
6.6.2 Market size, by product, 2016 - 2027 (USD Million)
6.6.2.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.6.2.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.6.2.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.6.2.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.6.2.5 Market size, by cytokines, 2016 - 2027 (USD Million)
6.6.3 Market size, by route of administration, 2016 - 2027 (USD Million)
6.6.4 South Africa
6.6.4.1 Market size, by product, 2016 - 2027 (USD Million)
6.6.4.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.6.4.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.6.4.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.6.4.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.6.4.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.6.4.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.6.5 Saudi Arabia
6.6.5.1 Market size, by product, 2016 - 2027 (USD Million)
6.6.5.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.6.5.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.6.5.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.6.5.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.6.5.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.6.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
6.6.6 UAE
6.6.6.1 Market size, by product, 2016 - 2027 (USD Million)
6.6.6.1.1 Market size, by MAB, 2016 - 2027 (USD Million)
6.6.6.1.2 Market size, by vaccines, 2016 - 2027 (USD Million)
6.6.6.1.3 Market size, by cancer growth blockers, 2016 - 2027 (USD Million)
6.6.6.1.4 Market size, by blood cell growth factors, 2016 - 2027 (USD Million)
6.6.6.1.5 Market size, by cytokines, 2016 - 2027 (USD Million
6.6.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
Chapter 7 Company Profiles
7.1 Competitive dashboard
7.2 AbbVie
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 Amgen
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 Astellas
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 AstraZeneca
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 Bayer
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 Bristol-Myers Squibb
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 Eisai
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
7.9 Eli Lilly and Company
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.9.5 SWOT analysis
7.10 F. Hoffmann-La Roche
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.10.5 SWOT analysis
7.11 GlaxoSmithKline
7.11.1 Business overview
7.11.2 Financial data
7.11.3 Product landscape
7.11.4 Strategic outlook
7.11.5 SWOT analysis
7.12 Incyte
7.12.1 Business overview
7.12.2 Financial data
7.12.3 Product landscape
7.12.4 Strategic outlook
7.12.5 SWOT analysis
7.13 Merck
7.13.1 Business overview
7.13.2 Financial data
7.13.3 Product landscape
7.13.4 Strategic outlook
7.13.5 SWOT analysis
7.14 Novartis
7.14.1 Business overview
7.14.2 Financial data
7.14.3 Product landscape
7.14.4 Strategic outlook
7.14.5 SWOT analysis
7.15 Otsuka
7.15.1 Business overview
7.15.2 Financial data
7.15.3 Product landscape
7.15.4 Strategic outlook
7.15.5 SWOT analysis
7.16 Pfizer
7.16.1 Business overview
7.16.2 Financial data
7.16.3 Product landscape
7.16.4 Strategic outlook
7.16.5 SWOT analysis
7.17 Sanofi
7.17.1 Business overview
7.17.2 Financial data
7.17.3 Product landscape
7.17.4 Strategic outlook
7.17.5 SWOT analysis
7.18 Seattle Genetics
7.18.1 Business overview
7.18.2 Financial data
7.18.3 Product landscape
7.18.4 Strategic outlook
7.18.5 SWOT analysis
7.19 Spectrum Pharmaceuticals
7.19.1 Business overview
7.19.2 Financial data
7.19.3 Product landscape
7.19.4 Strategic outlook
7.19.5 SWOT analysis
7.20 Takeda Pharmaceuticals
7.20.1 Business overview
7.20.2 Financial data
7.20.3 Product landscape
7.20.4 Strategic outlook
7.20.5 SWOT analysis

Data Tables
TABLE 1. Global cancer biological therapy market size, 2016 - 2020, (USD Million)
TABLE 2. Global cancer biological therapy market size, 2021 - 2027, (USD Million)
TABLE 3. Global cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 4. Global cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 5. Global cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 6. Global cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 7. Global cancer biological therapy market size, by region, 2016 - 2020 (USD Million)
TABLE 8. Global cancer biological therapy market size, by region, 2021 - 2027 (USD Million)
TABLE 9. Industry impact forces
TABLE 10. Monoclonal antibodies (MAB) market size, by region, 2016 - 2020, (USD Million)
TABLE 11. Monoclonal antibodies (MAB) market size, by region, 2021 - 2027, (USD Million)
TABLE 12. Naked MAB market size, by region, 2016 - 2020 (USD Million)
TABLE 13. Naked MAB market size, by region, 2021 - 2027 (USD Million)
TABLE 14. Conjugated MAB market size, by region, 2016 - 2020 (USD Million)
TABLE 15. Conjugated MAB market size, by region, 2021 - 2027 (USD Million)
TABLE 16. Bi specific MAB market size, by region, 2016 - 2020 (USD Million)
TABLE 17. Bi specific MAB market size, by region, 2021 - 2027 (USD Million)
TABLE 18. Vaccines market size, by region, 2016 - 2020, (USD Million)
TABLE 19. Vaccines market size, by region, 2021 - 2027, (USD Million)
TABLE 20. Preventive vaccines market size, by region, 2016 - 2020 (USD Million)
TABLE 21. Preventive vaccines market size, by region, 2021 - 2027 (USD Million)
TABLE 22. Therapeutic vaccines market size, by region, 2016 - 2020 (USD Million)
TABLE 23. Therapeutic vaccines market size, by region, 2021 - 2027 (USD Million)
TABLE 24. Cancer growth blockers market size, by region, 2016 - 2020, (USD Million)
TABLE 25. Cancer growth blockers market size, by region, 2021 - 2027, (USD Million)
TABLE 26. TKI market size, by region, 2016 - 2020 (USD Million)
TABLE 27. TKI market size, by region, 2021 - 2027 (USD Million)
TABLE 28. PI market size, by region, 2016 - 2020 (USD Million)
TABLE 29. PI market size, by region, 2021 - 2027 (USD Million)
TABLE 30. mTOR Inhibitors market size, by region, 2016 - 2020 (USD Million)
TABLE 31. mTOR Inhibitors market size, by region, 2021 - 2027 (USD Million)
TABLE 32. Blood cell growth factors market size, by region, 2016 - 2020, (USD Million)
TABLE 33. Blood cell growth factors market size, by region, 2021 - 2027, (USD Million)
TABLE 34. Lenograstim market size, by region, 2016 - 2020 (USD Million)
TABLE 35. Lenograstim market size, by region, 2021 - 2027 (USD Million)
TABLE 36. Filgrastim market size, by region, 2016 - 2020 (USD Million)
TABLE 37. Filgrastim market size, by region, 2021 - 2027 (USD Million)
TABLE 38. Cytokine market size, by region, 2016 - 2020, (USD Million)
TABLE 39. Cytokine market size, by region, 2021 - 2027, (USD Million)
TABLE 40. Interferons market size, by region, 2016 - 2020 (USD Million)
TABLE 41. Interferons market size, by region, 2021 - 2027 (USD Million)
TABLE 42. Interleukins market size, by region, 2016 - 2020 (USD Million)
TABLE 43. Interleukins market size, by region, 2021 - 2027 (USD Million
TABLE 44. Oral market size, by region, 2016 - 2020, (USD Million)
TABLE 45. Oral market size, by region, 2021 - 2027, (USD Million)
TABLE 46. Injectable market size, by region, 2016 - 2020, (USD Million)
TABLE 47. Injectable market size, by region, 2021 - 2027, (USD Million)
TABLE 48. North America cancer biological therapy market size, by country, 2016 - 2020 (USD Million)
TABLE 49. North America cancer biological therapy market size, by country, 2021 - 2027, (USD Million)
TABLE 50. North America cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 51. North America cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 52. North America cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 53. North America cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 54. North America cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 55. North America cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 56. North America cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 57. North America cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 58. North America cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 59. North America cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 60. North America cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 61. North America cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 62. North America cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 63. North America cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 64. U.S. cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 65. U.S. cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 66. U.S. cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 67. U.S. cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 68. U.S. cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 69. U.S. cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 70. U.S. cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 71. U.S. cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 72. U.S. cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 73. U.S. cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 74. U.S. cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 75. U.S. cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 76. U.S. cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 77. U.S. cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 78. Canada cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 79. Canada cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 80. Canada cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 81. Canada cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 82. Canada cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 83. Canada cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 84. Canada cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 85. Canada cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 86. Canada cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 87. Canada cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 88. Canada cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 89. Canada cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 90. Canada cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 91. Canada cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 92. Europe cancer biological therapy market size, by country, 2016 - 2020 (USD Million)
TABLE 93. Europe cancer biological therapy market size, by country, 2021 - 2027, (USD Million)
TABLE 94. Europe cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 95. Europe cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 96. Europe cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 97. Europe cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 98. Europe cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 99. Europe cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 100. Europe cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 101. Europe cancer biological therapy market size, by cancer growth b

List of Tables

TABLE 111. Germany cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 112. Germany cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 113. Germany cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 114. Germany cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 115. Germany cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 116. Germany cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 117. Germany cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 118. Germany cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 119. Germany cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 120. Germany cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 121. Germany cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 122. UK cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 123. UK cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 124. UK cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 125. UK cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 126. UK cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 127. UK cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 128. UK cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 129. UK cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 130. UK cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 131. UK cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 132. UK cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 133. UK cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 134. UK cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 135. UK cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 136. France cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 137. France cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 138. France cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 139. France cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 140. France cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 141. France cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 142. France cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 143. France cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 144. France cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 145. France cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 146. France cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 147. France cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 148. France cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 149. France cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 150. Italy cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 151. Italy cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 152. Italy cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 153. Italy cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 154. Italy cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 155. Italy cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 156. Italy cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 157. Italy cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 158. Italy cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 159. Italy cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 160. Italy cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 161. Italy cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 162. Italy cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 163. Italy cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 164. Spain cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 165. Spain cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 166. Spain cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 167. Spain cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 168. Spain cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 169. Spain cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 170. Spain cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 171. Spain cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 172. Spain cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 173. Spain cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 174. Spain cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 175. Spain cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 176. Spain cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 177. Spain cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 178. Asia Pacific cancer biological therapy market size, by country, 2016 - 2020 (USD Million)
TABLE 179. Asia Pacific cancer biological therapy market size, by country, 2021 - 2027, (USD Million)
TABLE 180. Asia Pacific cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 181. Asia Pacific cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 182. Asia Pacific cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 183. Asia Pacific cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 184. Asia Pacific cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 185. Asia Pacific cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 186. Asia Pacific cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 187. Asia Pacific cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 188. Asia Pacific cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 189. Asia Pacific cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 190. Asia Pacific cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 191. Asia Pacific cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 192. Asia Pacific cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 193. Asia Pacific cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 194. Japan cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 195. Japan cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 196. Japan cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 197. Japan cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 198. Japan cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 199. Japan cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 200. Japan cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 201. Japan cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 202. Japan cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 203. Japan cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 204. Japan cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 205. Japan cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 206. Japan cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 207. Japan cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 208. China cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 209. China cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 210. China cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 211. China cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 212. China cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 213. China cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 214. China cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 215. China cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 216. China cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 217. China cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 218. China cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 219. China cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 220. China cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 221. China cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 222. India cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 223. India cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 224. India cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 225. India cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 226. India cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 227. India cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 228. India cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 229. India cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 230. India cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 231. India cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 232. India cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 233. India cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 234. India cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 235. India cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 236. Australia cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 237. Australia cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 238. Australia cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 239. Australia cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 240. Australia cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 241. Australia cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 242. Australia cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 243. Australia cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 244. Australia cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 245. Australia cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 246. Australia cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 247. Australia cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 248. Australia cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 249. Australia cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 250. Latin America cancer biological therapy market size, by country, 2016 - 2020 (USD Million)
TABLE 251. Latin America cancer biological therapy market size, by country, 2021 - 2027, (USD Million)
TABLE 252. Latin America cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 253. Latin America cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 254. Latin America cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 255. Latin America cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 256. Latin America cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 257. Latin America cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 258. Latin America cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 259. Latin America cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 260. Latin America cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 261. Latin America cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 262. Latin America cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 263. Latin America cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 264. Latin America cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 265. Latin America cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 266. Brazil cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 267. Brazil cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 268. Brazil cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 269. Brazil cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 270. Brazil cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 271. Brazil cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 272. Brazil cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 273. Brazil cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 274. Brazil cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 275. Brazil cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 276. Brazil cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 277. Brazil cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 278. Brazil cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 279. Brazil cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 280. Argentina cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 281. Argentina cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 282. Argentina cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 283. Argentina cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 284. Argentina cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 285. Argentina cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 286. Argentina cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 287. Argentina cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 288. Argentina cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 289. Argentina cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 290. Argentina cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 291. Argentina cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 292. Argentina cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 293. Argentina cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 294. Mexico cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 295. Mexico cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 296. Mexico cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 297. Mexico cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 298. Mexico cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 299. Mexico cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 300. Mexico cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 301. Mexico cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 302. Mexico cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 303. Mexico cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 304. Mexico cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 305. Mexico cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 306. Mexico cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 307. Mexico cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 308. MEA cancer biological therapy market size, by country, 2016 - 2020 (USD Million)
TABLE 309. MEA cancer biological therapy market size, by country, 2021 - 2027, (USD Million)
TABLE 310. MEA cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 311. MEA cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 312. MEA cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 313. MEA cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 314. MEA cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 315. MEA cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 316. MEA cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 317. MEA cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 318. MEA cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 319. MEA cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 320. MEA cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 321. MEA cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 322. MEA cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 323. MEA cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 324. South Africa cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 325. South Africa cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 326. South Africa cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 327. South Africa cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 328. South Africa cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 329. South Africa cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 330. South Africa cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 331. South Africa cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 332. South Africa cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 333. South Africa cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 334. South Africa cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 335. South Africa cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 336. South Africa cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 337. South Africa cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 338. South Arabia cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 339. South Arabia cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 340. South Arabia cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 341. South Arabia cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 342. South Arabia cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 343. South Arabia cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 344. South Arabia cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 345. South Arabia cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 346. South Arabia cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 347. South Arabia cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 348. South Arabia cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 349. South Arabia cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 350. South Arabia cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 351. UAE cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)
TABLE 352. UAE cancer biological therapy market size, by product, 2016 - 2020 (USD Million)
TABLE 353. UAE cancer biological therapy market size, by product, 2021 - 2027, (USD Million)
TABLE 354. UAE cancer biological therapy market size, by MAB, 2016 - 2020 (USD Million)
TABLE 355. UAE cancer biological therapy market size, by MAB, 2021 - 2027 (USD Million)
TABLE 356. UAE cancer biological therapy market size, by vaccines, 2016 - 2020 (USD Million)
TABLE 357. UAE cancer biological therapy market size, by vaccines, 2021 - 2027 (USD Million)
TABLE 358. UAE cancer biological therapy market size, by cancer growth blockers, 2016 - 2020 (USD Million)
TABLE 359. UAE cancer biological therapy market size, by cancer growth blockers, 2021 - 2027 (USD Million)
TABLE 360. UAE cancer biological therapy market size, by blood cell growth factors, 2016 - 2020 (USD Million)
TABLE 361. UAE cancer biological therapy market size, by blood cell growth factors, 2021 - 2027 (USD Million)
TABLE 362. UAE cancer biological therapy market size, by cytokines, 2016 - 2020 (USD Million)
TABLE 363. UAE cancer biological therapy market size, by cytokines, 2021 - 2027 (USD Million)
TABLE 364. UAE cancer biological therapy market size, by route of administration, 2016 - 2020 (USD Million)
TABLE 365. UAE cancer biological therapy market size, by route of administration, 2021 - 2027, (USD Million)

Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 Global cancer biological therapy market size, 2016 – 2027, (USD Million)
FIG. 3 Growth potential analysis, by product
FIG. 4 Growth potential analysis, by route of administration
FIG. 5 Porter’s analysis
FIG. 6 Company matrix analysis
FIG. 7 PESTEL analysis
FIG. 8 Key segment trends, by product
FIG. 9 Key segment trends, by route of administration
FIG. 10 Key regional trends
FIG. 11 Competitive dashboard